SeraCare

SeraCare, a part of LGC's Clinical Diagnostics Division, is dedicated to advancing precision medicine and enhancing the understanding of diseases. Their innovative tools and technologies not only ensure the safe and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data for precision diagnostics. The company's portfolio comprises quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents. Their work contributes to the promise of precision medicine, ultimately resulting in a safer and more effective healthcare environment. Established in 1984 and based in the United States, SeraCare operates in the Biotechnology, Health Care, and Pharmaceutical industries. While details about their last investment and associated investors are not available, SeraCare's position in the field of precision medicine and diagnostics presents an intriguing opportunity for venture capital firms looking to invest in cutting-edge healthcare solutions.